Product Innovation Times
SEE OTHER BRANDS

Get your daily news on consumer products

CDC Reaffirms Stance on COVID Vaccinations for Kids

(MENAFN) In a decisive move, the Centers for Disease Control and Prevention (CDC) on Friday reaffirmed its stance recommending COVID-19 vaccinations for healthy children—provided that healthcare providers agree it's appropriate.

This announcement directly contradicts recent claims made by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who earlier in the week asserted that the CDC had scrapped the recommendation. HHS is the federal agency that oversees the CDC.

According to an updated immunization schedule posted on the CDC’s official website, “COVID-19 vaccination is recommended for people ages 6 months and older.” The updated guidance emphasizes a more individualized approach, encouraging what the CDC terms “shared clinical decision-making” between physicians, families, and patients.

“This provision would allow for COVID-19 vaccination in children aged 6 months and older based on shared clinical decision-making, allowing for vaccination of immunocompromised children,” the schedule explains.

The clarification comes in direct response to Kennedy’s misleading Tuesday announcement: “As of today (Tuesday), the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule,” he claimed.

Kennedy, a well-known vaccine skeptic, made the statement just days after Food and Drug Administration (FDA) Commissioner Dr. Marty Makary revealed that the agency intends to limit the availability of future COVID-19 vaccines to older adults and individuals with pre-existing conditions.

While the FDA signals a shift toward targeted vaccine distribution, the CDC remains committed to providing access to vaccinations for younger, otherwise healthy populations—highlighting a significant divergence in federal messaging.

The contrast marks a sharp pivot from the early pandemic-era push for broad, universal immunization.

MENAFN31052025000045017169ID1109619045


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service